DDAH1 and neoplasm: Furthermore, corroborating our observations in CRC and also opposing the results of RNA-seq expression data analysis, Ye et al. [48] showed DDAH1 downregulation in patient-derived tumor samples, associated with more aggressive phenotype and poor patient survival.